Aim: Polyethylene glycol modified mesoporous silica-coated bismuth nanohybrids (Bi@mSiO 2 -PEG) are fabricated for chemothermotherapy and multimodal imaging. Materials & methods: The Bi@mSiO 2 -PEG are synthesized by coating mesoporous SiO 2 onto metallic Bi cores, followed by PEG modification. Their cytotoxicity, photothermal effect, drug loading, antitumor effect and imaging abilities are evaluated. Results: The nanohybrids show good biocompatibility, strong near-infrared absorbance, high photothermal conversion efficiency (∼36.6%), prominent infrared thermal imaging and photothermal killing efficacy on cancer cells. Utilizing the nanohybrids as potent drug carriers, a synergistic antitumor effect through chemothermotherapy is realized. Thanks to the superhigh x-ray attenuation coefficient and strong photothermal ability, high-contrast photoacoustic and x-ray computed tomography imaging are achieved. Conclusion: These results reveal great potentials of the Bi@mSiO 2 -PEG for precise and efficient anticancer treatments.
(Evolution 300, Thermo Scientific, MA, USA) and Fourier transform infrared spectra (Nicolet 6700, Thermo Scientific), respectively.
Synthesis of the Bi nanocrystals
The Bi nanocrystals (NCs) were synthesized according to a literature procedure [51] with some modifications. In brief, glucose (20 g ) and Bi(NO 3 ) 3 ·5H 2 O (970 mg) were dissolved in PPD (175 ml) under mechanical stirring in a three-necked flask (250 ml), and then the mixture solution was heated to 80 • C, followed by rapid addition of the borane morpholine solution (250 mM, 24.4 ml, dissolved in PPD). During the reaction, the solution turned black gradually, clearly suggesting the formation of the Bi NCs. After 60 s, the system was transferred to an ice-cold water bath to quench the reaction. For the purification of the Bi NCs, the reaction mixture was mixed with DI water (200 ml), then centrifuged (12,000 rpm, 20 min) and washed three times with DI water. The obtained Bi NCs precipitate was lyophilized via a vacuum freeze dryer (FD-1A-50, Beijing Biocool Co., Ltd, Beijing, China) at −52
• C for 24 h according to the manufacturer's suggested procedures. The obtained NCs black powder was finally stored at 4
• C.
Synthesis of the Bi@mSiO 2 -PEG hybrid nanomaterials
In a three-necked flask (250 ml), Bi NCs (10 mg) and CTAB (0.3 g) were fully dispersed into DI water (50 ml) under water-bath ultrasound (10 min), then DI water (150 ml) and NaOH solution (1 mol·l -1 , 0.75 ml) were successively added in. After heated to 70
• C, the system was added dropwise with TEOS (2.5 ml) and ethyl acetate (15 ml), and then stirred for 6 h. Afterward, mPEG-Silane (10 mg) was added into the mixture, followed by further reaction for 2.5 h. The obtained product was centrifuged (12,000 rpm, 10 min) and washed three-times with ethyl future science group www.futuremedicine.com alcohol. To remove the CTAB surfactant, the above product (10 mg) and ammonium nitrate (100 mg) were fully dispersed in ethyl alcohol (40 ml) , and then heated to 50
• C for 2 h upon stirring. The obtained Bi@mSiO 2 -PEG nanomaterials were centrifuged and fully washed with DI water, followed by lyophilization for further use.
Study of photothermal heating effect Bi@mSiO 2 -PEG aqueous dispersions (1.0 ml) with gradient concentrations (0, 10, 50, 100, 200 μg·ml -1 ) were irradiated by the 808-nm laser (2.0 W·cm -2 ) for 10 min, and the system temperature was monitored every 1.0 s by a digital thermocouple (accuracy: 0.1
• C) during the whole irradiation. Meanwhile, an infrared thermal camera (Ti25, Fluke, WA, USA) was used to collect the infrared thermal images at selected time points. To assess their photothermal stability, the Bi@mSiO 2 -PEG dispersion (100 μg·ml -1 ) was exposed to 3 min of laser irradiation (laser on), followed by 3 min of laser off. The laser on-off cycle was continuously repeated for 5 times. To study the photothermal conversion efficiency (η) of Bi@mSiO 2 -PEG, the dispersion (100 μg·ml -1 ) was irradiated by a 808 nm laser till the system achieved the maximum temperature. Then, the laser was switched off to allow the system to naturally cool down to room temperature. During the whole process, the system temperature was monitored every 20 s.
PTT effect on cancer cells
HeLa cells were incubated with the Bi@mSiO 2 -PEG dispersion (100 μg·ml -1 ), and then irradiated by a 808-nm laser (2.0 W·cm -2 ) for 10 min. After that, the cells were stained by calcein AM (2.0 mol· -1 ) and PI (3.0 mol·l -1 ) to display the living and dead cells under an inverted fluorescence microscope (IX71, Olympus, Japan). To further assess the PTT efficacy, HeLa cells were first treated with Bi@mSiO 2 -PEG dispersions at different concentrations (0, 50, 100 μg·ml -1 ), followed by laser irradiation for 0, 1, 3 and 5 min, respectively. After washed with phosphatebuffered saline (PBS) for three-times, the cell viability was measured by the CCK-8 assay following the manufacturer suggested procedures.
DOX loading & release experiments
In brief, Bi@mSiO 2 -PEG powder (8.0 mg) was fully dispersed into PBS (35 ml, pH = 7.4), followed by the addition of the DOX-HCl solution (2.0 mg·ml -1 , 5.0 ml) under stirring for 5 min. After NaOH solution (1.0 mol·l -1 ,75 μl) was added to neutralize the HCl molecule, the reaction was kept in the dark under moderate stirring for 24 h. Finally, the DOX-loaded Bi@mSiO 2 -PEG nanohybrids (DOX⊂Bi@mSiO 2 -PEG) were purified by multiple centrifugation (11,000 rpm, 10 min, 4
• C) and washing. For drug release study, the powder of DOX⊂Bi@mSiO 2 -PEG (500 μg) was fully dispersed into PBS (2.0 ml, pH = 7.4 and 5.0), followed by moderate stirring in the dark at 37
• C. At selected time points, the dispersions were centrifuged to carefully collect the supernatant, and fresh PBS (2.0 ml) with the same pH values was added to continue the DOX release process. For laser-triggered drug release, the DOX⊂Bi@mSiO 2 -PEG dispersions (pH = 5.0) were treated with laser irradiation (2.0 W·cm -2 , 5 min) at predetermined time intervals. Afterward, the amount of released DOX at each time point was calculated by fluorescence spectrum analysis (fluorescence spectrophotometer, Cary Eclipse, Varian, CA, USA) of the collected supernatants.
Study of intracellular DOX delivery, nuclear morphology & chemotherapy effect
For intracellular delivery of DOX in cancer cells, HeLa cells (1 × 10 5 cells) were treated with the DOX⊂Bi@mSiO 2 -PEG dispersions (50 μg·ml -1 ) for 1, 3 and 5 h, respectively. Meanwhile, the cells incubated with pure culture medium were used as the control. For the study of cell nuclear morphology, HeLa cells were incubated with the DOX⊂Bi@mSiO 2 -PEG dispersions (0, 10, 20 μg·ml -1 ) for 24 h. After the treatments, the cells were fixed by paraformaldehyde solution (4%), and then stained with DAPI for fluorescence imaging observation.
To assess the materials' chemotherapy effect on cancer cells, HeLa cells were incubated with the DOX⊂Bi@mSiO 2 -PEG dispersions at different concentrations (0, 5, 10, 50, 100 μg·ml -1 ) for 24 h, followed by repeatedly washing with PBS to discard the excess nanoparticles. Meanwhile, HeLa cells treated by the Bi@mSiO 2 -PEG (no DOX loaded) dispersions with the same concentrations were used for comparison. The cell viability was measured by the CCK-8 assay.
Synergistic chemophotothermal therapy
Typically, HeLa cells were incubated with free DOX, the Bi@mSiO 2 -PEG or the DOX⊂Bi@mSiO 2 -PEG dispersions (0, 5, 10, 50, 100 μg·ml -1 , the free DOX concentration was equivalent to that of the loaded DOX in the DOX⊂Bi@mSiO 2 -PEG material) for 12 h, followed by repeatedly washing to remove the excess DOX and nanomaterials. Then, the cells were treated by 5 min of laser irradiation, and further incubated at 37
• C for 24 h. Finally, the CCK-8 assay was used to measure the cell viability.
Study of PA & CT imaging
All the animal experiments were carried out following the protocols approved by the Institutional Animal Care and Use Committee.
For in vitro PA imaging, the aqueous dispersions of Bi@mSiO 2 -PEG nanohybrids (concentration: 0, 10, 20, 40, 80, 160 μg·ml -1 ) were loaded into cylinder-like prostheses (made of agar gel, diameter ∼ 1.0 cm) and then imaged under the MSOT InVision 128 PA tomography system (iThera Medical, München, Germany). The PA signals were analyzed by calculating the average signal values over the region of interest. For in vivo PA imaging study, tumor-bearing BALB/c nude mice were intratumorally injected with the Bi@mSiO 2 -PEG dispersions (1.0 mg·ml -1 , 50 μl), and then anesthetized for PA scanning under the MSOT InVision 128 PA tomography system. PA imaging before the injection was also carried out as the control.
For in vitro CT imaging, the aqueous dispersions of Bi@mSiO 2 -PEG nanohybrids or the Bi 2 Se 3 nanoplates at gradient concentrations (0, 0.31, 0.63, 1.25, 2.5, 5, 10 mg·ml -1 ) were prepared for CT scanning under the small animal x-ray CT imaging system (Gamma Medica-Ideas, CA, USA). The CT values (Hounsfield Unit, HU) were analysed by calculating the average signals over the region of interest. For in vivo CT imaging study, tumor-bearing mice were intratumorally injected with the Bi@mSiO 2 -PEG dispersions (2.5 mg·ml -1 , 100 μl), and then anesthetized for CT imaging scanning under the small animal x-ray CT imaging system. CT imaging before the injection was also carried out as the control. The filtered back projection method of the CT imaging system was used to reconstruct all the CT images.
Results & discussion

Synthesis & characterization
The synthesis strategy of the Bi@mSiO 2 -PEG nanohybrids is shown in Figure 1 . First, the Bi NCs were synthesized via a simple chemical reducing method by using bismuth nitrate as the Bi source, glucose saturated 1,2-propanediol as the solvent and borane morpholine as the reducing agent. The morphology of the synthesized Bi NCs was characterized via TEM and SEM. Representative TEM and SEM images show that the obtained Bi NCs were well-defined faceted NCs with an average diameter of ∼ 46 nm (Figure 2A & B) . We performed the energy dispersive spectroscopy (EDS) and XRD measurements to analyze the chemical composition and the crystallization nature of the Bi NCs sample. In Figure 2C , only intense elemental signals of Bi were observed in the EDS analysis of the NCs sample, except for C and O elements derived from the carbon-coated sample substrate. In addition, the XRD pattern ( Figure 2D) indicates that all the diffraction peaks of the Bi NCs sample can be well indexed to the standard hexagonal Bi crystal (JCPDS Card No. 85-1330), suggesting their high crystallinity and purity.
For the mesoporous silica coating, the Bi NCs dispersion was mixed with CTAB which could serve as the mesostructural template, followed by the addition of TEOS under alkaline condition to form the silica shell after silicate hydrolyzation. After PEGylation and removal of the CTAB surfactant, the Bi@mSiO 2 -PEG with mesoporous silica coating was obtained. As in Figure 3A , the Bi@mSiO 2 -PEG nanohybrids present a distinctive core-shell nanostructure with an average size of ∼73 nm, estimated from the statistical analysis on multiple TEM images. The mSiO 2 shell with an average thickness of ∼ 12 nm was evenly wrapped around the Bi NC core. High-resolution TEM image (inset of Figure 3A Moreover, the specific surface area, pore volume and pore size distribution of Bi@mSiO 2 -PEG were studied via Brunauer-Emmett-Teller (BET) measurement. As in Figure 3C , the N 2 adsorption-desorption isotherm of Bi@mSiO 2 -PEG presents a typical type-IV isotherm with hysteresis loops, indicating their mesoporous structure. The specific surface area and total pore volume of Bi@mSiO 2 -PEG were determined to be ∼73.61 m 2 ·g -1 and ∼ 0.33 cm 3 ·g -1 , respectively. Meanwhile, the corresponding pore size analysis ( Figure 3D ) shows a rather narrow distribution with a peak at ∼ 2 nm. All these results clearly suggest the successful mesoporous SiO 2 coating of Bi@mSiO 2 -PEG.
Photothermal heating effect
The optical absorption property of Bi@mSiO 2 -PEG was measured by ultraviolet−visible−near infrared absorbance spectra, and the results ( Figure 4A ) show that Bi@mSiO 2 -PEG possesses a broad and strong absorption band ranging from 400 to 1000 nm. The absorption values of the dispersions at 808 nm show perfect linear increase with the concentrations (Supplementary Figure 2) . The remarkable absorption in the NIR area may benefit the photothermal capacity of Bi@mSiO 2 -PEG. We then investigated their photothermal effect by monitoring the temperature elevation of the aqueous dispersions of Bi@mSiO 2 -PEG at various concentrations (0, 10, 50, 100, 200 μg·ml -1 ) under 808 nm laser irradiation for 10 min. As in Figure 4B , remarkable temperature rise was observed for the dispersions of Bi@mSiO 2 -PEG upon laser irradiation, which was strictly irradiation time-and concentrationdependent. When the concentration gradually increased from 10 to 200 μg·ml -1 , the corresponding temperature elevation ( T) after 10-min irradiation was ∼12.9, 34.1, 48.7 and 53.5
• C, respectively (Supplementary Figure 3) . In sharp contrast, the system temperature of pure DI water only elevated ∼ 4.8
• C under the same test conditions. It should be pointed out that, for 200 μg·ml -1 of dispersion, the system temperature can reach ∼ 50.0
• C upon an irradiation as short as 2.5 min, and finally as high as ∼76.4
• C after 10-min irradiation. Such hyperthermia can efficiently eliminate cancer cells within a short time. Importantly, the remarkable photothermal effect of Bi@mSiO 2 -PEG can be also used for high-contrast IRT imaging ( Figure 4C ), with the signal intensity closely relying on the irradiation time and concentrations. IRT imaging provided by the Bi@mSiO 2 -PEG nanohybrids is capable of real-time monitoring on the thermal dynamics of PTT process. Moreover, we assessed the photothermal conversion stability of the Bi@mSiO 2 -PEG by irradiated the dispersion (100 μg·ml -1 ) with the 808 nm laser for five repeated cycles (3 min irradiation for each cycle). As shown in Figure 4D , the nanohybrids could maintain the temperature elevation ability during the whole cycles, supporting their excellent photothermal stability. Therefore, upon photothermal cycling, the Bi@mSiO 2 -PEG nanohybrids are more stable than the Au-based nanoagents (Au nanorods and nanoshells), which showed degraded photothermal conversion capability after irradiations [46, 52] .
To quantitatively evaluate the photothermal effect of Bi@mSiO 2 -PEG, we measured their photothermal conversion efficiency (η) by continuously irradiating the materials' dispersion (100 μg·ml -1 ) for 20 min to attain the maximum temperature, followed by naturally cooling to room temperature. Upon the identical irradiation, the dispersion attained a maximum T ∼ 50.1
• C, which was much higher than that of pure DI water (∼ 5.6
• C) ( Figure 4E ). According to the standard calculation method reported in previous literature [53] , the photothermal conversion efficiency of Bi@mSiO 2 -PEG was determined to be ∼36.6% based on the linearly fitting data (Figure 4F ) deduced from the system cooling curve in Figure 4E . This value is higher than that of the widely-reported future science group www.futuremedicine.com Au-based nanoagents (21% for Au nanorods, 13% for Au nanoshells [54] ). Therefore, such Bi@mSiO 2 -PEG hybrid nanoplatform with strong NIR absorbance, high photothermal conversion efficiency/stability and IRT imaging capacity may show great potentials for PTT cancer treatment.
Biocompatibility study
As the biocompatibility of a nanoagent is an important concern for biomedical application, we carefully assessed their potential cytotoxicity effect and hemolytic activity. The stability of Bi@mSiO 2 -PEG nanohybrids in different physiological solutions was explored. The results ( Figure S4 ) indicate the excellent compatibility and stability of the nanohybrids in water and various physiological solutions, such as PBS, Dulbecco's modified Eagle's medium and fetal bovine serum, without forming macroscopic aggregations upon over 1 week storage. The standard CCK-8 assay was performed to study the cytotoxicity of Bi@mSiO 2 -PEG to HeLa cells (as cancer cell model) and human umbilical vein endothelial cells (as normal cell model), respectively. As shown in Figure 5A and B, cell viability of both HeLa and human umbilical vein endothelial cells were barely jeopardized after incubated with the Bi@mSiO 2 -PEG dispersions at various concentrations (0-200 μg·ml -1 ) for either 24 h or 48 h, with a survival rate higher than 90% in all cases, clearly indicating a negligible cytotoxicity of the materials at the tested doses.
To further check their biocompatibility, we then studied the hemolysis effect of Bi@mSiO 2 -PEG. Red blood cells (RBCs) were isolated from fresh blood sample and incubated with the Bi@mSiO 2 -PEG dispersions at various concentrations (0-800 μg·ml -1 ). DI water (+) and PBS (-) were used as the control groups. The hemolysis percent Figure 5C indicate negligible hemolysis behavior of Bi@mSiO 2 -PEG, thus directly suggesting their excellent blood compatibility. Therefore, all these results demonstrate that the Bi@mSiO 2 -PEG nanomaterials possess good biocompatibility, which is favorable for biomedical applications.
IRT imaging & PTT effect on cancer cells
Prior to studying the PTT killing efficacy, we first investigated the IRT imaging performance on cancer cells. HeLa cells were incubated with Bi@mSiO 2 -PEG, followed by NIR irradiation. As shown in Figure 6A cells. To comparatively assess the PTT killing efficacy, we performed the CCK-8 assay to evaluate the cell viability of HeLa cells after treated by Bi@mSiO 2 -PEG and laser irradiation. As shown in Figure 6B , the cell viability of HeLa cells dramatically decreased after treated with the nanohybrids plus laser irradiation, and such prominent photothermal killing effect followed irradiation time-and concentration-dependent modes. For instance, the cell viability values for the 50 μg·ml -1 were ∼85.7, 25.4 and 15.1% after irradiation for 1, 3 and 5 min, respectively; while for 100 μg·ml -1 , the values were ∼39.3, 15.4 and 6.4%. In contrast, there were no noticeable changes of the cell viability observed for the cells treated only by the nanohybrids or the laser irradiation.
We further performed the live-dead cell staining assay to intuitively display the PTT killing effect of Bi@mSiO 2 -PEG on cancer cells. After treated with Bi@mSiO 2 -PEG incubation and laser irradiation, HeLa cells were stained by calcein-AM (green fluorescence) and PI (red fluorescence) for the observation of the living and dead cells. As in Figure 6C , consistent with the CCK-8 assay, only the group of Bi@mSiO 2 -PEG plus laser irradiation (c 4 ) caused a remarkable cell death, while HeLa cells of the whole well showed vivid green with negligible red fluorescence signals after treated by either laser irradiation (c 2 ) or Bi@mSiO 2 -PEG alone (c 3 ), which was comparable to the control group with no treatments (c 1 ). Therefore, these above results clearly suggest the powerful NIR-mediated photothermal killing effect of Bi@mSiO 2 -PEG on cancer cells, thus revealing a great potential of the hybrid nanoplatform for PTT application. DOX loading, release & synergistic chemophotothermal therapy Due to their large specific surface area and abundant mesoporous derived from the mesoporous silica coating, the Bi@mSiO 2 -PEG nanohybrids may have been endowed a high loading capability of drugs for chemotherapy.
As a proof-of-concept model, DOX (a broad-spectrum chemotherapy drug in clinic) was chosen to be loaded into the hybrid nanocarriers. After DOX loading, the color of the obtained DOX⊂Bi@mSiO 2 -PEG dispersion changed from black to purple-black. We used Fourier transform infrared spectra to confirm the DOX loading in the materials. As shown in Figure 7A , compared with Bi@mSiO 2 -PEG, the DOX-loaded nanohybrids exhibited characteristic DOX absorption peaks at ∼1581 cm -1 (C=C stretching vibration of aromatic ring) and ∼1081 cm -1 (C-O stretching vibration). Moreover, the results of fluorescence emission spectra ( Figure 7B ) further reveal the successful DOX loading, in other words, DOX⊂Bi@mSiO 2 -PEG shows the characteristic photoluminescence future science group www.futuremedicine.com emission peaks corresponding to DOX under 480 nm excitation, while the Bi@mSiO 2 -PEG materials have no emission under the same test conditions. We measured the DOX loading content of the DOX⊂Bi@mSiO 2 -PEG using the standard fluorescence calibration curve, and the loading capacity was determined to be ∼12.6%, which is significant considering the high weight ratio of the Bi core. We then studied the drug release property of the DOX⊂Bi@mSiO 2 -PEG in PBS solutions with different pH values (∼7.4 and 5.0). The two pH conditions were to simulate the normal physiological environment (neutral) and tumor microenvironment (acidic), respectively. As in Figure 7C , the DOX release rate from the DOX⊂Bi@mSiO 2 -PEG closely relies on the release time and pH values. For example, the released DOX content at pH = 4.8 was ∼14.6% at 1 h, ∼29.8% at 3 h and ∼43.2% at 7 h, while the values at pH = 7.4 were much lower than that of the acidic condition. The pH-sensitive release behavior can be mainly attributed to the fast amino protonation and increased solubility of DOX molecules at acidic pH [55] . In addition, the drug-release rate can also be accelerated by laser irradiation, probably due to the weak interaction between the nanohybrids and DOX induced by the promoted thermal vibration [26] . The bimodal pH/laser-responsive drug-release capacity of DOX⊂Bi@mSiO 2 -PEG is favorable for on-demand drug delivery to tumor site for accurate chemotherapy with minimized risk to normal cells.
To intuitively display the intracellular drug delivery of DOX⊂Bi@mSiO 2 -PEG, HeLa cells were incubated with its dispersions (50 μg·ml -1 ) for different times (1, 3, 5 h), then stained by DAPI for fluorescence imaging. As in Figure 8 , striking red DOX fluorescence signals in HeLa cells were clearly observed after incubated with DOX⊂Bi@mSiO 2 -PEG, revealing the efficient intracellular DOX delivery in cancer cells. Such cellular delivery followed a time-dependent manner, as the DOX fluorescent signals were markedly enhanced when the incubation time was extended from 1 to 5 h. As comparison, no obvious DOX fluorescence signals were found in the control group without the naoparticles.
The chemotherapy effect of DOX⊂Bi@mSiO 2 -PEG on HeLa cells was then investigated via the cell nuclear morphology and cell viability measurements. For nuclear morphology study, HeLa cells were incubated with the nanohybrids dispersions (0, 10, 20 μg·ml -1 ) for 24 h, followed by staining the nuclear with DAPI. As shown in Figure 9A -C, the cell amount markedly decreased, and significant karyopyknosis with abnormal nucleus fragments (marked by arrows) was observed in the cells after treated by DOX⊂Bi@mSiO 2 -PEG, revealing their potent chemotherapy effect. More abnormal fragments could be found at higher concentrations, suggesting their dosedependent manner. Then, the CCK-8 assay was carried out to quantitatively evaluate the chemotherapy effect of the hybrid nanomaterials. The results are shown in Figure 9D . It is revealed that DOX⊂Bi@mSiO 2 -PEG can cause a remarkable decrease (relying on the concentrations) on the cell viability of HeLa cells, while Bi@mSiO 2 -PEG (without DOX) hardly reduced the cell viability. Particularly, at a concentration of 100 μg·ml -1 , ∼92.3% of HeLa cells were killed after 24 h incubation, revealing their efficient chemotherapy effect on cancer cells. Therefore, these above results clearly demonstrated that the hybrid nanomaterials can act as an effective drug-delivery nanosystem for inhibition of cancer cells.
The combination of chemotherapy and PTT by DOX⊂Bi@mSiO 2 -PEG hybrids was then studied. HeLa cells were first incubated with the nanomaterials for 12 h, then exposed to 5 min laser irradiation, followed by further incubation for 24 h. The CCK-8 assay was performed to evaluate the therapeutic efficacy. As shown in Figure 9E , a more pronounced killing effect was observed for the DOX⊂Bi@mSiO 2 -PEG + laser group (chemophotothermal therapy) at all the tested concentrations, compared with either the free DOX group (chemotherapy) or the Bi@mSiO 2 -PEG + laser group (PTT). For instance, the killing efficacy of the chemophotothermal therapy reached as high as ∼91.8%, significantly higher than that of either PTT (72.3%) or chemotherapy (∼79.8%) at a concentration of 50 μg·ml -1 . Such synergistic therapeutic effect may be attributed to the increased cellular uptake and drug-release induced by the local hyperthermia generated by the hybrid nanomaterials [56] . Therefore, our results directly demonstrate that the DOX⊂Bi@mSiO 2 -PEG hybrid nanomaterials can realize a superior synergetic antitumor effect upon laser irradiation, and may hold a promising application for cancer treatment.
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PA & CT Imaging
Besides the efficient therapeutic functions, the Bi@mSiO 2 -PEG nanomaterials can also be used for PA and CT dualmodal imaging due to their strong photothermal conversion ability and superhigh x-ray attenuation coefficient. Utilizing these multiple imaging capacities, comprehensive information about tumor size, location and profile can be obtained toward a precise therapy. First, the PA imaging capacity was assessed in vitro by scanning the nanomaterials' aqueous dispersions at various concentrations (0, 10, 20, 40, 80, and 160 μg·ml -1 ) under the PA imaging system. It can be seen from Figure 10A that the PA images became brighter at higher concentrations, revealing the gradually incremental PA signal intensity. Figure 10B shows that the corresponding PA signal values increased linearly with the materials concentrations (R 2 = 0.99), clearly suggesting their excellent PA imaging ability. To study the in vivo PA imaging performance of the Bi@mSiO 2 -PEG hybrid nanomaterials, HeLa tumor-bearing BALB/c nude mice were intratumorally injected with the materials dispersions, followed by anesthetization for PA scanning. As shown in Figure 10C , no PA signals were observed before the injection (Pre), while the tumor site with the Bi@mSiO 2 -PEG injection (Post) showed strong PA signals, suggesting their remarkable PA imaging ability in vivo.
Given the high x-ray attenuation coefficient of Bi element, the possible application of the Bi-enriched hybrid nanomaterails for CT imaging was also studied. The CT imaging performance in vitro was first evaluated by scanning the Bi@mSiO 2 -PEG dispersions at gradient concentrations (0, 0.31, 0.63, 1.25, 2.5, 5, 10 mg·ml -1 ) under the CT imaging system. For comparison, the CT contrast performance of the Bi 2 Se 3 nanoplates (a typical bismuth chalcogenide reported for high-performance CT imaging [57] ) was also measured at the same test conditions. As shown in Figure 10D , progressively brighter CT phantom images were observed for both the Bi 2 Se 3 nanoplates (A sample) and Bi@mSiO 2 -PEG nanohybrids (B sample) at higher concentrations; while the image brightness of the hybrid nanomaterials was much higher than that of Bi 2 Se 3 nanoplates at the same concentrations, revealing their faster incremental CT intensity over Bi 2 Se 3 . The corresponding calculated CT value of each sample ( Figure 10E ) further directly confirmed the result. The CT values of both the Bi@mSiO 2 -PEG nanohybrids and Bi 2 Se 3 nanoplates were increased linearly (R 2 = 0.99) along with their concentrations. Remarkably, the nanohybrids showed a much higher CT contrast enhanced efficiency (∼54.8 HU·ml·mg -1 ) than that of Bi 2 Se 3 nanoplates (∼27.6 HU·ml·mg -1 ). The superhigh CT efficiency of Bi@mSiO 2 -PEG is also much higher than that of most other CT agents reported previously, such as commercial iopromide [58] , bismuth chalcogenide-based [26, 37] , Au-based [59, 60] , W-based agents [42] , thus demonstrating their competent CT imaging capacity. We finally explored the potential of the Bi@mSiO 2 -PEG hybrid nanomaterials for in vivo CT imaging on tumor-bearing Balb/c nude mice. As shown in Figure 10F , strong CT response in the tumor site was clearly observed after intratumorally injection of the materials (Post), in sharp contrast to CT imaging results before the injection (Pre). Therefore, all these results show considerable potentials of the Bi@mSiO 2 -PEG hybrid nanoplatform for high-performance CT imaging application.
Conclusion
In summary, we have successfully fabricated a versatile theranostic nanosystem based on the core-shell Bi@mSiO 2 -PEG hybrid nanomaterials for multimodal imaging and synergistic chemophotothermal therapy. The resultant hybrids show good biocompatibility, strong NIR absorbance, high photothermal conversion efficiency and conversion stability. Upon NIR laser irradiation, the hybrid nanomaterials can realize prominent IRT imaging, and mediate efficient photothermal ablation of cancer cells. Moreover, DOX has been efficiently loaded into the mesoporous structure of the core-shell nanohybrids, exhibiting pH/NIR-triggered dual-modal drug release behavior for efficient intracellular drug delivery and chemotherapy. Most importantly, combining PTT and chemotherapy together can realize a more superior antitumor efficacy compared with either monotherapy alone. Besides IRT imaging, the Bi@mSiO 2 -PEG hybrid nanomaterials have been also used for high-contrast PA and CT imaging due to their excellent photothermal conversion ability and superhigh x-ray attenuation coefficient. Overall, our present study suggests the great potentials of the Bi@mSiO 2 -PEG-based core-shell nanoplatform as a novel multifunctional theranostic nanoagent for highly precise and efficient antitumor treatments.
Future perspective
It is highly desirable to incorporate the photothermal function of the Bi nanohybrids with the capability of drug delivery to accomplish a synergistic effect based on chemophotothermal therapy with multimodal imaging.
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Summary points
• To develop theranostic nanoagents that incorporate powerful therapeutic effect with high-performance imaging and drug loading capacity a nanohybrids of metallic bismuth cores coated by polyethylene glycol modified mesoporous silica (Bi@mSiO 2 -PEG) have been fabricated.
• The Bi@mSiO 2 -PEG nanohybrids show excellent application in chemo-thermotherapy.
• The Bi@mSiO 2 -PEG nanohybrids show multimodal imaging, including photoacoustic imaging, x-ray computed tomography and infrared thermal imaging.
• The Bi@mSiO 2 -PEG nanohybrids show good biocompatibility, strong near-infrared absorbance and high photothermal conversion efficiency (∼36.6%).
• The Bi@mSiO 2 -PEG has become a potent intracellular drug carrier, where the drug-release can be efficiently triggered by external stimuli including low pH environment and irradiation.
• The synergistic chemothermotherapy of Bi@mSiO 2 -PEG nanohybrids is remarkably superior to either photothermal therapy or chemotherapy alone.
• The Bi@mSiO 2 -PEG nanohybrids have high performance on computed tomography and photoacoustic imaging is achieved both in vitro and in vivo.
• The Bi@mSiO 2 -PEG hybrid nanoplatform may hold great promise for precise and efficient tumor imaging and therapy.
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